InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Henney Christopher S, Director. Insider active across 2 companies, notably Cyclacel Pharmaceuticals, Inc.. In total, 7 disclosures have been published. Activity tracked since 15 June 2021. The latest transaction was disclosed on 30 June 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Henney Christopher S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
21,219 shares0Common StockSEC:0001104659-23-077651:0
15,822 shares0Common StockSEC:0001104659-22-071893:0
11,108 shares@ US$11.3326.1% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-013567:0
17,500 shares@ US$9.230.026% mcap12.5% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-21-024235:0
17,500 shares@ US$9.2333.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-21-024156:0
12,000 shares@ US$16.4340.5% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-012739:0
2,374 shares0Common StockSEC:0001104659-21-082599:0
7 of 7 declarations
About Henney Christopher S
Christopher S. Henney is a Board Member at Cyclacel Pharmaceuticals, Inc. and PROTHENA CORP PUBLIC LTD CO. In these roles, he contributes to the governance of the companies and strategic decision-making. His experience in the pharmaceutical sector allows him to bring valuable insights to help guide development and innovation strategies.
